Clinical Trial Update: DKN-01 Inhibition in Advanced Liver Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for DKN-01 inhibition in hepatocellular carcinoma (advanced liver cancer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• DKN-01 (dkn-01)

Snippet

Sponsor: Johannes Gutenberg University Mainz | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN